EGFR and non-small cell lung carcinoma: To detect the expression of LOC554202 and miR-31 levels in NSCLC patients treated with EGFR-TKI, we collected 11 advanced NSCLC patients with acquired resistance to gefitinib and total RNA was isolated from plasma of 11 patients at the time points of before and after gefitinib treatment.